Ticker Details
Charles River Laboratories International, Inc. Charles River Laboratories International Inc is a pharmaceutical company providing drug discovery and development services. The company provides animal models for laboratory testing, and offers manufacturing testing services to various industries.
IPO Date:	June 23, 2000
Sector:	Healthcare
Industry:	Life Sciences Tools and Services
Market Cap:	$14.09B
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$1.51 | 1.27%
Avg Daily Range (30 D):	$4.36 | 1.76%
Avg Daily Range (90 D):	$4.28 | 2.14%

Institutional Daily Volume
Avg Daily Volume:	.54M
Avg Daily Volume (30 D):	.74M
Avg Daily Volume (90 D):	.68M

Trade Size
Avg Trade Size (Sh.):	84
Avg Trade Size (Sh.) (30 D):	39
Avg Trade Size (Sh.) (90 D):	39

Institutional Trades
Total Institutional Trades:	13,824
Avg Institutional Trade:	$4.57M
Avg Institutional Trade (30 D):	$17.47M
Avg Institutional Trade (90 D):	$16.03M
Avg Institutional Trade Volume:	.04M
Avg Institutional Trades (Per Day):	2

Market Closing Trades
Avg Closing Trade:	$9.49M
Avg Closing Trade (30 D):	$34.15M
Avg Closing Trade (90 D):	$31.28M
Avg Closing Volume:	59.76K

News

Jul 15, 2026 @ 10:46 AM Global Clinical Trials Market to Reach $176.32 Bil... Source: Researchandmarkets.Com

Jun 18, 2026 @ 5:00 PM Global Cell and Gene Therapy CDMO Market Anticipat... Source: Delveinsight

May 25, 2026 @ 8:15 AM Cell Banking Outsourcing Market: 16%+ CAGR (2026-2... Source: Mordor Intelligence

May 4, 2026 @ 5:00 PM Global Plasmid DNA Manufacturing Market Anticipate... Source: Delveinsight

Apr 28, 2026 @ 5:00 PM Global AAV Vector Manufacturing Market Gearing Up ... Source: Delveinsight

Financials
	TTM	Q2 2026	Q1 2026
Basic EPS	$-4.79	$-.03	$-.3
Diluted EPS	$-4.79	$-.03	$-.3
Revenue	$4B	$1B	$995.83M
Gross Profit
Net Income / Loss	$-236.3M	$-.76M	$-14.8M
Operating Income / Loss	$90.14M	$119.89M	$119.9M
Cost of Revenue
Net Cash Flow	$55.84M	$42.38M	$-17.8M
PE Ratio